Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Pregnancy and multiple sclerosis.
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
ACRM I American Congress of Rehabilitation
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Clinical Trials
Episode 4 with Dr. Michael Racke on the Kir4.1 potassium channel
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
MS clinical trials: what can subgroup analyses teach us?
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Delayed visual evoked response in optic neuritis.
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials

Pages